The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReckitt Regulatory News (RKT)

Share Price Information for Reckitt (RKT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,484.00
Bid: 4,483.00
Ask: 4,485.00
Change: 15.00 (0.34%)
Spread: 2.00 (0.045%)
Open: 4,472.00
High: 4,521.00
Low: 4,468.00
Prev. Close: 4,469.00
RKT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Closing sale of IFCN China business to Primavera

9 Sep 2021 09:24

RNS Number : 2682L
Reckitt Benckiser Group PLC
09 September 2021
 

Reckitt announces closing of sale of IFCN business in China to Primavera 

 

9 September 2021 - Slough, UK - Reckitt Benckiser Group plc ("Reckitt") is pleased to announce that it has today completed the sale, announced on 5 June 2021, of its Infant Formula and Child Nutrition ("IFCN") business in China* to Primavera Capital Group ("Primavera"). 

 

All conditions to completion of the transaction have been satisfied.

 

Commenting on the sale, Reckitt CEO Laxman Narasimhan said: 

 

"Coming just six-and-a-half months after announcing the strategic review in February, the closing today represents a major step forward in our strategy to rejuvenatesustainable growth. Our Nutrition business is now stronger and more concentrated in attractive markets such as North America, Latin America and ASEAN. We remain fully focused on executing our strategy, investing for growth and achieving our medium-term targets.

 

"To those Reckitt team members who will start a new chapter today, I want to thank you for all of your contributions to Reckitt and wish you well."  

* Mainland China, Taiwan, Hong Kong

 

 

For further information, please contact:

Reckitt 

Simon Whittington 

Deputy Head of Investor Relations 

 

+44 (0)7408 812062 

Patty O'Hayer 

Director, External Relations and Government Affairs 

 

+44 (0)7825 755688 

Finsbury 

Faeth Birch 

 

+44 (0)7768 943171 

 

 

 

About Reckitt 

 

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege. 

 

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more. 

 

Every day, more than 20 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always. 

 

We are a diverse global team of more than 43,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more, or get in touch with us at www.reckitt.com

 

*Reckitt is the trading name of the Reckitt Benckiser group of companies 

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISUPUGPBUPGURB
Date   Source Headline
23rd May 20225:28 pmRNSDirector/PDMR Shareholding
20th May 20225:30 pmRNSResult of AGM
3rd May 202212:54 pmRNSTotal Voting Rights
29th Apr 20227:00 amRNS1st Quarter Results
27th Apr 20224:29 pmRNSNotice of AGM
14th Apr 202212:26 pmRNSAnnual Financial Report
1st Apr 20221:57 pmRNSTotal Voting Rights
22nd Mar 202212:18 pmRNSDirector/PDMR Shareholding
1st Mar 20223:39 pmRNSTotal Voting Rights
17th Feb 20227:00 amRNSReckitt FY 2021 Results
1st Feb 202210:32 amRNSTotal Voting Rights
17th Jan 20229:00 amRNSDirectorate Change
4th Jan 202211:21 amRNSTotal Voting Rights
24th Dec 20217:00 amRNSProposed Sale of E45 to Karo Pharma
1st Dec 202111:22 amRNSTotal Voting Rights
1st Nov 202111:47 amRNSTotal Voting Rights
26th Oct 202110:01 amRNSDirectorate Change
26th Oct 20217:00 amRNS3rd Quarter Results
4th Oct 20219:35 amRNSDirectorate Change
1st Oct 202111:15 amRNSTotal Voting Rights
23rd Sep 20217:00 amRNSTrading Update & Launch of Investor Seminar Series
16th Sep 20211:20 pmRNSDirector/PDMR Shareholding
9th Sep 20219:24 amRNSClosing sale of IFCN China business to Primavera
1st Sep 202111:08 amRNSTotal Voting Rights
31st Aug 20214:00 pmRNSDirector/PDMR Shareholding
4th Aug 202110:30 amRNSDirector/PDMR Shareholding
3rd Aug 20211:30 pmRNSDirector/PDMR Shareholding
2nd Aug 202112:50 pmRNSTotal Voting Rights
30th Jul 202110:57 amRNSDirector Declaration
29th Jul 20213:30 pmRNSDirector/PDMR Shareholding
28th Jul 20214:00 pmRNSDirector/PDMR Shareholding
28th Jul 202110:00 amRNSDirector/PDMR Shareholding
27th Jul 20217:00 amRNSHalf-Year Report
1st Jul 202111:23 amRNSTotal Voting Rights
25th Jun 20212:45 pmRNSDirector Declaration
23rd Jun 20214:25 pmRNSDirector/PDMR Shareholding
17th Jun 202111:31 amRNSDirector/PDMR Shareholding
7th Jun 20217:00 amRNSReckitt to sell IFCN China for US $2.2billion
1st Jun 20212:20 pmRNSDirector/PDMR Shareholding
1st Jun 202112:43 pmRNSTotal Voting Rights
28th May 20216:09 pmRNSResult of AGM
4th May 202111:58 amRNSTotal Voting Rights
28th Apr 20217:00 amRNS1st Quarter Results
8th Apr 202110:14 amRNSAnnual Financial Report
1st Apr 202112:14 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.